Loading organizations...
Quest for Growth operates as a closed-end investment company and a public alternative investment fund (AIF) under Belgian law. It specializes in strategic equity investments in growth companies, aiming to generate capital gains. The company identifies and supports high-potential enterprises, realizing returns through equity appreciation.
Founded in 1998, Quest for Growth was shaped by Jos B. Peeters, founder and managing director of Capricorn Venture Partners NV, which manages the fund. Peeters’ background, including seven years as managing director of BeneVent Management, provided crucial venture and investment expertise. This insight offered public investors direct participation in innovative companies.
Quest for Growth serves public investors seeking capital appreciation from emerging businesses. Its vision is to be a key financial enabler for innovative enterprises, fostering their development and market expansion. Through disciplined investment in dynamic growth firms, the company aims to deliver sustained capital returns to its shareholders, contributing to the venture ecosystem.
Quest for Growth has 8 tracked investments across 5 companies. The latest tracked deal is $3.2M Other Equity in EclecticIQ in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 25, 2024 | EclecticIQ | $3.2M Other Equity | Dutch Security TechFund | ACE Capital Partners, Arches Capital, Capricorn Venture Partners, INKEF Capital, Keen Venture Partners, KPN Ventures |
| Nov 1, 2020 | EclecticIQ | $24.0M Series C | François Lavaste | INKEF Capital, TIN Capital, Arches Capital, Katrin Geyskens, BEN Verwaayen, KPN Ventures |
| Sep 2, 2020 | Miracor Medical SA | $28.5M Series E | — | Earlybird, Noshaq, Sfpi Fpim, Sriw, Yonghua Capital |
| Sep 4, 2018 | Miracor Medical SA | $34.8M Series D | Ming Capital | Noshaq, Sfpi |
| Jan 17, 2018 | HalioDx | $22.6M Series B | — | BNP Paribas Développement, MI Care, PSIM Fund, Sham Innovation Sant, Sofipaca |
| May 24, 2012 | Prosonix | $26.8M Series B | — | Entrepreneurs Fund, GIMV, Solon Ventures, Ventech |
| Jul 7, 2011 | Prosonix | $18.2M Other Equity | — | Entrepreneurs Fund, Solon Ventures, Karl Nagler |
| Oct 1, 2007 | Syntaxin | $32.0M Series B | SR ONE, René Kuijten | Abingworth, EQT Life Sciences, RED Tree Venture Capital, Zeev Zehavi |
